Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry

BACKGROUNDS: Treatment of difficult-to-treat rheumatoid arthritis (D2T RA) is one of the greatest unmet needs in rheumatology. This study aims to find out preferable treatment options for a group of D2T RA patients who are refractory to multiple biologic and targeted synthetic disease-modifying anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochi, Sae, Sonomoto, Koshiro, Nakayamada, Shingo, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886884/
https://www.ncbi.nlm.nih.gov/pubmed/35232462
http://dx.doi.org/10.1186/s13075-022-02744-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886884/
https://www.ncbi.nlm.nih.gov/pubmed/35232462
http://dx.doi.org/10.1186/s13075-022-02744-7

Ejemplares similares